Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
506365 STARSOURCE

Starsource Multitrade Share Price

 

 

Starsource Multitrade live price: ₹110. It opened at ₹110 vs previous close ₹110; intraday high/low: ₹110/₹110. The 50 & 200 DMA stand at ₹107.33/₹111.63.

Starsource Multitrade Performance

  • Today's Low
  • ₹110
  • Today's High
  • ₹110
  • 52 Week Low
  • ₹75
  • 52 Week High
  • ₹153
  • Open Price₹110
  • Previous Close₹110
  • Volume190
  • 50 DMA₹107.33
  • 100 DMA₹109.96
  • 200 DMA₹111.63

Starsource Multitrade Chart

Investment Returns

  • Over 1 Month + 8.99%
  • Over 3 Month -15.74%
  • Over 6 Month -11.43%
  • Over 1 Year -17.88%

Smart Investing Starts Here Start SIP with Starsource Multitrade for Steady Growth!

Invest Now

Starsource Multitrade Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -1.4
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 17
  • P/B Ratio
  • 12.2
  • Average True Range
  • 5.73
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 4.54
  • RSI
  • 52.09
  • MFI
  • 42.9

Starsource Multitrade Financials

Starsource Multitrade Technicals

EMA & SMA

Current Price
₹110.00
0 (0%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹109.90
  • 50 Day
  • ₹107.33
  • 100 Day
  • ₹109.96
  • 200 Day
  • ₹111.63

Resistance and Support

110 Pivot Speed
  • R3 110.00
  • R2 110.00
  • R1 110.00
  • S1 110.00
  • S2 110.00
  • S3 110.00

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Starsource Multitrade Ltd has an operating revenue of Rs. 1.22 Cr. on a trailing 12-month basis. An annual revenue de-growth of -66% needs improvement, Pre-tax margin of 0% needs improvement, ROE of 2% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 24 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 48 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Starsource Multitrade Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-13 Quarterly Results
2025-08-22 Others Inter-alia, to consider 1. Request letter dated 11/08/2025 received for reclassification of the status by Ms. Shanta Somani from "Promoter Group Shareholder" to "Public Shareholder"
2025-08-12 Quarterly Results & A.G.M.
2025-07-31 Others Inter-alia 1. To consider and accept resignation of existing statutory auditors. 2. To appoint fresh statutory auditors to fill the casual vacancy.

Starsource Multitrade F&O

Starsource Multitrade Shareholding Pattern

27.89%
0.17%
65.82%
6.12%

Starsource Multitrade FAQs

Starsource Multitrade share price is ₹110 As on 26 April, 2026 | 14:12

The Market Cap of Starsource Multitrade is ₹16.5 Cr As on 26 April, 2026 | 14:12

The P/E ratio of Starsource Multitrade is -1.4 As on 26 April, 2026 | 14:12

The PB ratio of Starsource Multitrade is 12.2 As on 26 April, 2026 | 14:12

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23